enalkiren has been researched along with ro 42-5892 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deinum, J; Derkx, FH; Fischli, W; Lipovski, M; Schalekamp, MA; Verhaar, M | 1 |
| Hiwada, K | 1 |
| Boger, RS; Glassman, HN; Luther, RR | 1 |
| Lenders, JW; Rongen, GA; Smits, P; Thien, T | 1 |
| Foote, EF; Halstenson, CE | 1 |
| Clozel, JP; Fischli, W | 1 |
| Claridge, S; Hanessian, S; Johnstone, S | 1 |
| Alexis, MN; Avramopoulos, A; Czyżnikowska, Ż; Leonis, G; Mavromoustakos, T; Papadopoulos, MG; Papavasileiou, KD; Peristeras, LD; Reis, H; Tzoupis, H; Vergadou, N; Zerva, S | 1 |
4 review(s) available for enalkiren and ro 42-5892
| Article | Year |
|---|---|
[Renin inhibitors].
Topics: Animals; Antihypertensive Agents; Dipeptides; Humans; Hypertension; Imidazoles; Morpholines; Renin | 1992 |
Renin inhibitors in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dipeptides; Humans; Hypertension; Imidazoles; Oligopeptides; Renin; Renin-Angiotensin System | 1991 |
Clinical pharmacokinetics and efficacy of renin inhibitors.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Biological Availability; Dipeptides; Hemodynamics; Humans; Imidazoles; Morpholines; Oligopeptides; Protease Inhibitors; Renin; Renin-Angiotensin System; Tissue Distribution | 1995 |
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Dipeptides; Heart Failure; Humans; Hypertension; Imidazoles; Losartan; Renin; Tetrazoles | 1993 |
4 other study(ies) available for enalkiren and ro 42-5892
| Article | Year |
|---|---|
Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody.
Topics: Antibodies, Monoclonal; Binding Sites; Dipeptides; Enzyme Activation; Enzyme Precursors; Fibrinolysin; Humans; Imidazoles; Kidney; Kinetics; Mathematics; Oligopeptides; Renin; Thermodynamics | 1992 |
Comparative effects of three different potent renin inhibitors in primates.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Cilazapril; Dipeptides; Drug Interactions; Heart Rate; Humans; Imidazoles; In Vitro Techniques; Injections, Intravenous; Oligopeptides; Renin; Renin-Angiotensin System; Saimiri; Time Factors | 1993 |
The power of visual imagery in synthesis planning. Stereocontrolled approaches to CGP-60536B, a potent renin inhibitor.
Topics: Alkylation; Anisoles; Crystallography, X-Ray; Dipeptides; Enzyme Inhibitors; Histidine; Imidazoles; Molecular Conformation; Molecular Structure; Morpholines; Oligopeptides; Renin; Stereoisomerism; Structure-Activity Relationship | 2002 |
Elucidation of the binding mechanism of renin using a wide array of computational techniques and biological assays.
Topics: Catalytic Domain; Dipeptides; Enzyme Assays; Hydrogen Bonding; Imidazoles; Molecular Dynamics Simulation; Protease Inhibitors; Protein Binding; Renin; Thermodynamics | 2015 |